AIM
INSM icon

Advantage Investment Management’s Insmed INSM Stock Holding History

Advantage Investment Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-500
Closed -$9K – 871
2015
Q3 		$9K Hold
500
– – 0.01% 557
2015
Q2 		$12K Hold
500
– – 0.01% 553
2015
Q1 		$10K Sell
500
-500
-50% -$8.81K 0.01% 584
2014
Q4 		$15K Buy
+1,000
New +$14.2K 0.01% 462

Other funds holding INSM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Advantage Investment Management's INSM Position: Q4 2015 in Review

Advantage Investment Management sold out of Insmed (INSM) in Q4 2015, closing a stake of 500 shares — an estimated $9K sold.

Advantage Investment Management first reported a position in INSM in Q4 2014 and held it in 4 quarters. The position peaked at $15K in Q4 2014. 114 funds tracked by Wall St. Rank hold INSM as of Q4 2015.

  • Advantage Investment Management reported no remaining Insmed position as of Q4 2015 after selling out during the quarter.
  • Advantage Investment Management sold 500 Insmed shares in Q4 2015, an estimated $9K.
  • Advantage Investment Management first reported a position in Insmed in Q4 2014 and held it in 4 quarters.
  • Advantage Investment Management's Insmed position peaked at $15K in Q4 2014.
  • 114 funds tracked by Wall St. Rank held Insmed as of Q4 2015.

Based on Advantage Investment Management's 13F filing for Q4 2015, filed 27 Mar 2017.